Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Holweg, CTJ; Baan, CC; Niesters, HGM; Vantrimpont, PJMJ; Mulder, PGH; Maat, APWM; Weimar, W; Balk, AHMM
   TGF-beta 1 gene polymorphisms in patients with end-stage heart failure
   JOURNAL OF HEART AND LUNG TRANSPLANTATION
   
   C.T.J. Holweg et al., "TGF-beta 1 gene polymorphisms in patients with end-stage heart failure", J HEART LUN, 20(9), 2001, pp. 979-984
2. de Groot-Kruseman, HA; Baan, CC; Loonen, EHM; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
   Failure to down-regulate intragraft cytokine mRNA expression shortly afterclinical heart transplantation is associated with high incidence of acute rejection
   JOURNAL OF HEART AND LUNG TRANSPLANTATION
   
   H.A. de Groot-Kruseman et al., "Failure to down-regulate intragraft cytokine mRNA expression shortly afterclinical heart transplantation is associated with high incidence of acute rejection", J HEART LUN, 20(5), 2001, pp. 503-510
3. Elhendy, A; van Domburg, RT; Vantrimpont, P; Sozzi, FB; Bax, JJ; Poldermans, D; Roelandt, JRTC; Maat, LPWM; Balk, AHMM
   Impact of heart transplantation on the safety and feasibility of the dobutamine stress test
   JOURNAL OF HEART AND LUNG TRANSPLANTATION
   
   A. Elhendy et al., "Impact of heart transplantation on the safety and feasibility of the dobutamine stress test", J HEART LUN, 20(4), 2001, pp. 399-406
4. de Leeuw, N; Ruiter, DJ; Balk, AHMM; de Jonge, N; Melchers, WJG; Galama, JMD
   Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy
   TRANSPLANT INTERNATIONAL
   
   N. de Leeuw et al., "Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy", TRANSPLAN I, 14(5), 2001, pp. 299-306
5. Baan, CC; van Riemsdijk-van Overbeeke, IC; Balk, AHMM; Vantrimpont, PMAJ; Mol, WM; Knoop, CJ; Niesters, HGM; Maat, LPWM; Weimar, W
   Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression
   CLINICAL TRANSPLANTATION
   
   C.C. Baan et al., "Conversion from cyclosporin A to tacrolimus is safe and decreases blood pressure, cholesterol levels and TGF-beta 1 type I receptor expression", CLIN TRANSP, 15(4), 2001, pp. 276-283
6. Hesse, CJ; Vantrimpont, P; van Riemsdijk-van Overbeeke, IC; van Gelder, T; Balk, AHMM; Weimar, W
   The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation
   TRANSPLANTATION PROCEEDINGS
   
   C.J. Hesse et al., "The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation", TRANSPLAN P, 33(3), 2001, pp. 2163-2164
7. de Groot-Kruseman, HA; Baan, CC; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
   Cyclosporine A downregulates intragraft platelet-derived growth factor-alpha mRNA expression after clinical heart transplantation
   TRANSPLANTATION PROCEEDINGS
   
   H.A. de Groot-Kruseman et al., "Cyclosporine A downregulates intragraft platelet-derived growth factor-alpha mRNA expression after clinical heart transplantation", TRANSPLAN P, 33(3), 2001, pp. 2241-2243
8. Holweg, CTJ; Baan, CC; Balk, AHMM; Niesters, HGM; Maat, APWM; Mulder, PMG; Weimar, W
   The transforming growth factor-beta 1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation
   TRANSPLANTATION
   
   C.T.J. Holweg et al., "The transforming growth factor-beta 1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation", TRANSPLANT, 71(10), 2001, pp. 1463-1467
9. Baan, CC; Balk, AHMM; Holweg, CTJ; van Riemsdijk, IC; Maat, LPWM; Vantrimpont, PJMJ; Niesters, HGM; Weimar, W
   Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism
   JOURNAL OF HEART AND LUNG TRANSPLANTATION
   
   C.C. Baan et al., "Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism", J HEART LUN, 19(9), 2000, pp. 866-872
10. Elhendy, A; Sozzi, FB; van Domburg, RT; Vantrimpont, P; Valkema, R; Krenning, EP; Roelandt, JRTC; Maat, LPWM; Balk, AHMM
    Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    A. Elhendy et al., "Accuracy of dobutamine tetrofosmin myocardial perfusion imaging for the noninvasive diagnosis of transplant coronary artery stenosis", J HEART LUN, 19(4), 2000, pp. 360-366
11. Vaessen, LMB; van Miert, PPMC; van der Mast, BJ; Doumaid, K; Balk, AHMM; Boog, CJP; Weimar, W
    Immunologic monitoring of the beneficial effect of one HLA-DR-shared bloodtransfusion in heart transplant patients
    JOURNAL OF HEART AND LUNG TRANSPLANTATION
    
    L.M.B. Vaessen et al., "Immunologic monitoring of the beneficial effect of one HLA-DR-shared bloodtransfusion in heart transplant patients", J HEART LUN, 19(11), 2000, pp. 1098-1107
12. Koelman, CA; Vaessen, LMB; Balk, AHMM; Weimar, W; Doxiadis, IIN; Claas, FHJ
    Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients
    TRANSPLANT IMMUNOLOGY
    
    C.A. Koelman et al., "Donor-derived soluble HLA plasma levels can not be used to monitor graft rejection in heart transplant recipients", TRANSPL IMM, 8(1), 2000, pp. 57-64
13. Balk, AHMM
    Dilated cardiomyopathy, are a few drinks allowed?
    EUROPEAN HEART JOURNAL
    
    A.H.M.M. Balk, "Dilated cardiomyopathy, are a few drinks allowed?", EUR HEART J, 21(4), 2000, pp. 267-269
14. Baan, CC; van Gelder, T; Balk, AHMM; Knoop, CJ; Holweg, CTJ; Maat, LPWM; Weimar, W
    Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection
    TRANSPLANTATION
    
    C.C. Baan et al., "Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection", TRANSPLANT, 69(3), 2000, pp. 331-336
15. van den Berg-Emons, HJG; Bussmann, JBJ; Balk, AHMM; Stam, HJ
    Validity of ambulatory accelerometry to quantify physical activity in heart failure
    SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE
    
    H.J.G. van den Berg-Emons et al., "Validity of ambulatory accelerometry to quantify physical activity in heart failure", SC J RE MED, 32(4), 2000, pp. 187-192
16. Wijbenga, AAM; Balk, AHMM; Jonkman, FAM; Boomsma, F; Simoons, ML; 't Veld, AJMI
    Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure
    EUROPEAN JOURNAL OF HEART FAILURE
    
    A.A.M. Wijbenga et al., "Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure", EUR J HE FA, 1(1), 1999, pp. 51-58
17. de Leeuw, N; Melchers, WJG; Balk, AHMM; de Jonge, N; Galama, JMD
    Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy
    CLINICAL INFECTIOUS DISEASES
    
    N. de Leeuw et al., "Study an microbial persistence in end-stage idiopathic dilated cardiomyopathy", CLIN INF D, 29(3), 1999, pp. 522-525
18. de Groot-Kruseman, HA; Baan, CC; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
    Intragraft platelet-derived growth factor-alpha and transforming growth factor-beta 1 during the development of accelerated graft vascular disease after clinical heart transplantation
    TRANSPLANT IMMUNOLOGY
    
    H.A. de Groot-Kruseman et al., "Intragraft platelet-derived growth factor-alpha and transforming growth factor-beta 1 during the development of accelerated graft vascular disease after clinical heart transplantation", TRANSPL IMM, 7(4), 1999, pp. 201-205
19. Balk, AHMM
    The 'heart failure nurse' to help us close the gap between what we can andwhat we do achieve
    EUROPEAN HEART JOURNAL
    
    A.H.M.M. Balk, "The 'heart failure nurse' to help us close the gap between what we can andwhat we do achieve", EUR HEART J, 20(9), 1999, pp. 632-633
20. Wijbenga, JAM; Balk, AHMM; Boomsma, F; in't Veld, AJM; Hall, C
    Cardiac peptides differ in their response to exercise - Implications for patients with heart failure in clinical practice
    EUROPEAN HEART JOURNAL
    
    J.A.M. Wijbenga et al., "Cardiac peptides differ in their response to exercise - Implications for patients with heart failure in clinical practice", EUR HEART J, 20(19), 1999, pp. 1424-1428
21. van Riemsdijk-van Overbeeke, IC; Baan, CC; Niesters, HGM; Hesse, CJ; Loonen, EHM; Balk, AHMM; Maat, APWM; Weimar, W
    The TNF-alpha system in heart failure and after heart transplantation - Plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity
    EUROPEAN HEART JOURNAL
    
    I.C. van Riemsdijk-van Overbeeke et al., "The TNF-alpha system in heart failure and after heart transplantation - Plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity", EUR HEART J, 20(11), 1999, pp. 833-840
22. de Groot-Kruseman, HA; Baan, CC; Mol, WM; Niesters, HGM; Maat, APWM; Balk, AHMM; Weimar, W
    Upregulated transforming growth factor-beta(1) mRNA expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation
    TRANSPLANTATION PROCEEDINGS
    
    H.A. de Groot-Kruseman et al., "Upregulated transforming growth factor-beta(1) mRNA expression in endomyocardial biopsies during the development of graft vascular disease after clinical heart transplantation", TRANSPLAN P, 31(7), 1999, pp. 2724-2725
23. Baan, CC; Knoop, CJ; Holweg, CTJ; van Gelder, T; Metselaar, HJ; Niesters, HGM; Zondervan, PE; Balk, AHMM; Weimar, W
    The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation
    TRANSPLANTATION PROCEEDINGS
    
    C.C. Baan et al., "The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantation", TRANSPLAN P, 31(7), 1999, pp. 2726-2728
24. Baan, CC; Knoop, CJ; van Gelder, T; Holweg, CTJ; Niesters, HGM; Smeets, TJM; van der Ham, F; Zondervan, PE; Maat, LPWM; Balk, AHMM; Weimar, W
    Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation
    TRANSPLANTATION
    
    C.C. Baan et al., "Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation", TRANSPLANT, 67(6), 1999, pp. 870-876
25. de Leeuw, N; Melchers, WJG; Ruiter, DJ; Caforio, ALP; Balk, AHMM; de Jonge, N; Galama, JMD
    Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy
    JOURNAL OF CLINICAL PATHOLOGY
    
    N. de Leeuw et al., "Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathy", J CLIN PATH, 52(10), 1999, pp. 739-743
26. Vaessen, LMB; Daane, CR; Maat, APWM; Balk, AHMM; Claas, FHJ; Weimar, W
    T helper frequencies in peripheral blood reflect donor-directed reactivityin the graft after clinical heart transplantation
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    L.M.B. Vaessen et al., "T helper frequencies in peripheral blood reflect donor-directed reactivityin the graft after clinical heart transplantation", CLIN EXP IM, 118(3), 1999, pp. 473-479
27. Wijbenga, AAM; Mosterd, A; Kasprzak, JD; Ligthart, JMR; Vletter, WB; Balk, AHMM; Roelandt, JRTC
    Potentials and limitations of the Valsalva maneuver as a method of differentiating between normal and pseudonormal left ventricular filling patterns
    AMERICAN JOURNAL OF CARDIOLOGY
    
    A.A.M. Wijbenga et al., "Potentials and limitations of the Valsalva maneuver as a method of differentiating between normal and pseudonormal left ventricular filling patterns", AM J CARD, 84(1), 1999, pp. 76-81
28. BAAN CC; HOLWEG CTJ; NIESTERS HGM; VANGELDER T; MOL WM; ZONDERVAN PE; MOCHTAR B; BALK AHMM; WEIMAR W
    THE NATURE OF ACUTE REJECTION IS ASSOCIATED WITH DEVELOPMENT OF GRAFTVASCULAR-DISEASE AFTER CLINICAL HEART-TRANSPLANTATION
    The Journal of heart and lung transplantation
    
    C.C. Baan et al., "THE NATURE OF ACUTE REJECTION IS ASSOCIATED WITH DEVELOPMENT OF GRAFTVASCULAR-DISEASE AFTER CLINICAL HEART-TRANSPLANTATION", The Journal of heart and lung transplantation, 17(4), 1998, pp. 363-373
29. OSTERHAUS ADME; VOS MC; BALK AHMM; DEMAN RA; MOUTON JW; ROTHBARTH PH; SCHALM SW; TOMAELLO AM; NIESTERS HGM; VERBRUGH HA
    TRANSMISSION OF HEPATITIS-B VIRUS AMONG HEART-TRANSPLANT RECIPIENTS DURING ENDOMYOCARDIAL BIOPSY PROCEDURES
    The Journal of heart and lung transplantation
    
    A.D.M.E. Osterhaus et al., "TRANSMISSION OF HEPATITIS-B VIRUS AMONG HEART-TRANSPLANT RECIPIENTS DURING ENDOMYOCARDIAL BIOPSY PROCEDURES", The Journal of heart and lung transplantation, 17(2), 1998, pp. 158-166
30. VANEMMERIK NEM; VAESSEN LMB; KNOOP CJ; DAANE CR; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    KINETICS OF CIRCULATING CYTOTOXIC T-LYMPHOCYTE PRECURSORS THAT HAVE AHIGH AVIDITY FOR DONOR ANTIGENS - CORRELATION WITH THE REJECTION STATUS OF THE HUMAN CARDIAC ALLOGRAFT
    Transplant immunology
    
    N.E.M. Vanemmerik et al., "KINETICS OF CIRCULATING CYTOTOXIC T-LYMPHOCYTE PRECURSORS THAT HAVE AHIGH AVIDITY FOR DONOR ANTIGENS - CORRELATION WITH THE REJECTION STATUS OF THE HUMAN CARDIAC ALLOGRAFT", Transplant immunology, 6(3), 1998, pp. 153-160
31. VANGELDER T; BALK AHMM; ZONDERVAN PE; MAAT AWPW; MOCHTAR B; VANDERMEER P; WEIMAR W
    C-REACTIVE PROTEIN IN THE MONITORING OF ACUTE REJECTION AFTER HEART-TRANSPLANTATION
    Transplant international
    
    T. Vangelder et al., "C-REACTIVE PROTEIN IN THE MONITORING OF ACUTE REJECTION AFTER HEART-TRANSPLANTATION", Transplant international, 11(5), 1998, pp. 361-364
32. VANGELDER T; BALK AHMM; ZIETSE R; HESSE C; MOCHTAR B; WEIMAR W
    RENAL-INSUFFICIENCY AFTER HEART-TRANSPLANTATION - A CASE-CONTROL STUDY
    Nephrology, dialysis, transplantation
    
    T. Vangelder et al., "RENAL-INSUFFICIENCY AFTER HEART-TRANSPLANTATION - A CASE-CONTROL STUDY", Nephrology, dialysis, transplantation, 13(9), 1998, pp. 2322-2326
33. KOELMAN CA; MULDER A; JUTTE NHPM; VAESSEN LMB; BALK AHMM; WEIMAR W; DOXIADIS IIN; CLAAS FHJ
    THE APPLICATION OF HUMAN MONOCLONAL-ANTIBODIES FOR MONITORING DONOR DERIVED SOLUBLE HLA CLASS-I MOLECULES IN THE SERUM OF HEART-TRANSPLANT RECIPIENTS
    Human immunology
    
    C.A. Koelman et al., "THE APPLICATION OF HUMAN MONOCLONAL-ANTIBODIES FOR MONITORING DONOR DERIVED SOLUBLE HLA CLASS-I MOLECULES IN THE SERUM OF HEART-TRANSPLANT RECIPIENTS", Human immunology, 59(2), 1998, pp. 106-114
34. WIJBENGA JAM; BALK AHMM; MEIJ SH; SIMOONS ML; MALIK M
    HEART-RATE-VARIABILITY INDEX IN CONGESTIVE-HEART-FAILURE - RELATION TO CLINICAL-VARIABLES AND PROGNOSIS
    European heart journal
    
    J.A.M. Wijbenga et al., "HEART-RATE-VARIABILITY INDEX IN CONGESTIVE-HEART-FAILURE - RELATION TO CLINICAL-VARIABLES AND PROGNOSIS", European heart journal, 19(11), 1998, pp. 1719-1724
35. BAAN CC; KNOOP CJ; VANGELDER T; VANDERHAM F; ZONDERVAN PE; HOLWEG CTJ; MOCHTAR B; BALK AHMM; WEIMAR W
    CONTRIBUTION OF THE INFLAMMATORY RESPONSE TO CARDIAC ALLOGRAFT-REJECTION - HISTOPATHOLOGIC ANALYSIS OF SERIAL ENDOMYOCARDIAL BIOPSIES
    Transplantation proceedings
    
    C.C. Baan et al., "CONTRIBUTION OF THE INFLAMMATORY RESPONSE TO CARDIAC ALLOGRAFT-REJECTION - HISTOPATHOLOGIC ANALYSIS OF SERIAL ENDOMYOCARDIAL BIOPSIES", Transplantation proceedings, 30(4), 1998, pp. 1104-1106
36. VANGELDER T; BALK AHMM; ZIETSE R; HESSE C; MOCHTAR B; WEIMAR W
    SURVIVAL OF HEART-TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-INDUCED RENAL-INSUFFICIENCY
    Transplantation proceedings
    
    T. Vangelder et al., "SURVIVAL OF HEART-TRANSPLANT RECIPIENTS WITH CYCLOSPORINE-INDUCED RENAL-INSUFFICIENCY", Transplantation proceedings, 30(4), 1998, pp. 1122-1123
37. Weimar, W; van Besouw, NM; Baan, CC; Balk, AHMM
    Cytotoxic T lymphocytes and cytokines in graft vascular disease after clinical heart transplantation
    TRANSPLANTATION PROCEEDINGS
    
    W. Weimar et al., "Cytotoxic T lymphocytes and cytokines in graft vascular disease after clinical heart transplantation", TRANSPLAN P, 30(8), 1998, pp. 3996-3998
38. VANEMMERIK NEM; KNOOP CJ; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLASS FHJ; WEIMAR W
    C1.7 MONOCLONAL-ANTIBODY DESIGNATES HIGH-AVIDITY CD4(-LYMPHOCYTES INVOLVED IN CLINICAL HEART REJECTION() CYTOTOXIC T)
    Transplantation
    
    N.E.M. Vanemmerik et al., "C1.7 MONOCLONAL-ANTIBODY DESIGNATES HIGH-AVIDITY CD4(-LYMPHOCYTES INVOLVED IN CLINICAL HEART REJECTION() CYTOTOXIC T)", Transplantation, 66(1), 1998, pp. 135-138
39. VANGELDER T; BAAN CC; BALK AHMM; KNOOP CJ; HOLWEG CTJ; VANDERMEER P; MOCHTAR B; ZONDERVAN PE; NIESTERS HGM; WEIMAR W
    BLOCKADE OF THE INTERLEUKIN (IL)-2 IL-2 RECEPTOR PATHWAY WITH A MONOCLONAL, ANTI-IL-2 RECEPTOR ANTIBODY (BT563) DOES NOT PREVENT THE DEVELOPMENT OF ACUTE HEART ALLOGRAFT-REJECTION IN HUMANS/
    Transplantation
    
    T. Vangelder et al., "BLOCKADE OF THE INTERLEUKIN (IL)-2 IL-2 RECEPTOR PATHWAY WITH A MONOCLONAL, ANTI-IL-2 RECEPTOR ANTIBODY (BT563) DOES NOT PREVENT THE DEVELOPMENT OF ACUTE HEART ALLOGRAFT-REJECTION IN HUMANS/", Transplantation, 65(3), 1998, pp. 405-410
40. WIJBURG ER; BALK AHMM; VANHERWERDEN LA
    DOUBLE VALVE REPAIR IN A TRANSPLANTED HEART
    Journal of thoracic and cardiovascular surgery
    
    E.R. Wijburg et al., "DOUBLE VALVE REPAIR IN A TRANSPLANTED HEART", Journal of thoracic and cardiovascular surgery, 115(1), 1998, pp. 250-251
41. DELEEUW N; MELCHERS WJG; BALK AHMM; DEJONGE N; GALAMA JMD
    NO EVIDENCE FOR PERSISTENT ENTEROVIRUS INFECTION IN PATIENTS WITH END-STAGE IDIOPATHIC DILATED CARDIOMYOPATHY
    The Journal of infectious diseases
    
    N. Deleeuw et al., "NO EVIDENCE FOR PERSISTENT ENTEROVIRUS INFECTION IN PATIENTS WITH END-STAGE IDIOPATHIC DILATED CARDIOMYOPATHY", The Journal of infectious diseases, 178(1), 1998, pp. 256-259
42. VANBESOUW NM; LOONEN EHM; VAESSEN LMB; BALK AHMM; CLAAS FHJ; WEIMAR W
    THE FREQUENCY AND AVIDITY OF COMMITTED CYTOTOXIC T-LYMPHOCYTES (CCTL)FOR DONOR HLA CLASS-I AND CLASS-II ANTIGENS AND THEIR RELATION WITH GRAFT VASCULAR-DISEASE
    Clinical and experimental immunology
    
    N.M. Vanbesouw et al., "THE FREQUENCY AND AVIDITY OF COMMITTED CYTOTOXIC T-LYMPHOCYTES (CCTL)FOR DONOR HLA CLASS-I AND CLASS-II ANTIGENS AND THEIR RELATION WITH GRAFT VASCULAR-DISEASE", Clinical and experimental immunology, 111(3), 1998, pp. 548-554
43. JUTTE NHPM; KNOOP CJ; HEIJSE P; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    CYTOTOXICITY OF GRAFT-DERIVED LYMPHOCYTES - SPECIFIC FOR DONOR HEART ENDOTHELIAL-CELLS
    The Journal of heart and lung transplantation
    
    N.H.P.M. Jutte et al., "CYTOTOXICITY OF GRAFT-DERIVED LYMPHOCYTES - SPECIFIC FOR DONOR HEART ENDOTHELIAL-CELLS", The Journal of heart and lung transplantation, 16(2), 1997, pp. 209-215
44. VANEMMERIK NEM; LOONEN EHM; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    THE AVIDITY, NOT THE MERE PRESENCE, OF PRIMED CYTOTOXIC T-LYMPHOCYTESFOR DONOR HUMAN-LEUKOCYTE CLASS-II ANTIGENS DETERMINES THEIR CLINICALRELEVANCE AFTER HEART-TRANSPLANTATION
    The Journal of heart and lung transplantation
    
    N.E.M. Vanemmerik et al., "THE AVIDITY, NOT THE MERE PRESENCE, OF PRIMED CYTOTOXIC T-LYMPHOCYTESFOR DONOR HUMAN-LEUKOCYTE CLASS-II ANTIGENS DETERMINES THEIR CLINICALRELEVANCE AFTER HEART-TRANSPLANTATION", The Journal of heart and lung transplantation, 16(2), 1997, pp. 240-249
45. BAAN CC; VANBESOUW NM; DAANE CR; BALK AHMM; MOCHTAR B; NIESTERS HGM; WEIMAR W
    KINETICS OF IL-2 AND IL-4 MESSENGER-RNA AND PROTEIN-PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES RESPONSIBLE FOR REJECTION AFTER CLINICAL HEART-TRANSPLANTATION
    Transplant immunology
    
    C.C. Baan et al., "KINETICS OF IL-2 AND IL-4 MESSENGER-RNA AND PROTEIN-PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES RESPONSIBLE FOR REJECTION AFTER CLINICAL HEART-TRANSPLANTATION", Transplant immunology, 5(2), 1997, pp. 97-103
46. BAAN CC; HOLWEG CTJ; NIESTERS HGM; VANGELDER T; MOL WM; MOCHTAR B; BALK AHMM; WEIMAR W
    INTRAGRAFT CYTOKINE AND GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN RELATION TO GRAFT VASCULAR-DISEASE AFTER HEART-TRANSPLANTATION
    Transplantation proceedings
    
    C.C. Baan et al., "INTRAGRAFT CYTOKINE AND GROWTH-FACTOR MESSENGER-RNA EXPRESSION IN RELATION TO GRAFT VASCULAR-DISEASE AFTER HEART-TRANSPLANTATION", Transplantation proceedings, 29(6), 1997, pp. 2535-2536
47. VANBESOUW NM; DAANE CR; VAESSEN LMB; VANGELDER T; MOCHTAR B; BALK AHMM; WEIMAR W
    NONSPECIFIC IMMUNE REACTIVITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IS RELATED TO GRAFT VASCULAR-DISEASE
    Transplantation proceedings
    
    N.M. Vanbesouw et al., "NONSPECIFIC IMMUNE REACTIVITY OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS IS RELATED TO GRAFT VASCULAR-DISEASE", Transplantation proceedings, 29(6), 1997, pp. 2544-2545
48. VANBESOUW NM; DAANE CR; VAESSEN LMB; MOCHTAR B; BALK AHMM; WEIMAR W
    DONOR-SPECIFIC CYTOKINE PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES INDUCES AND MAINTAINS GRAFT VASCULAR-DISEASE IN HUMAN CARDIAC ALLOGRAFTS
    Transplantation
    
    N.M. Vanbesouw et al., "DONOR-SPECIFIC CYTOKINE PRODUCTION BY GRAFT-INFILTRATING LYMPHOCYTES INDUCES AND MAINTAINS GRAFT VASCULAR-DISEASE IN HUMAN CARDIAC ALLOGRAFTS", Transplantation, 63(9), 1997, pp. 1313-1318
49. VANDERMAST BJ; BALK AHMM
    EFFECT OF HLA-DR-SHARED BLOOD-TRANSFUSION ON THE CLINICAL OUTCOME OF HEART-TRANSPLANTATION
    Transplantation
    
    B.J. Vandermast e A.H.M.M. Balk, "EFFECT OF HLA-DR-SHARED BLOOD-TRANSFUSION ON THE CLINICAL OUTCOME OF HEART-TRANSPLANTATION", Transplantation, 63(10), 1997, pp. 1514-1519
50. VANEMMERIK NEM; DAANE CR; KNOOP CJ; HESSE C; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    THE AVIDITY OF ALLOSPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) DETERMINES THEIR CYTOKINE PRODUCTION PROFILE
    Clinical and experimental immunology
    
    N.E.M. Vanemmerik et al., "THE AVIDITY OF ALLOSPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) DETERMINES THEIR CYTOKINE PRODUCTION PROFILE", Clinical and experimental immunology, 110(3), 1997, pp. 447-453
51. VANSUYLEN RJ; VANBEKKUM EEC; BOERSMA H; DEKOK LB; BALK AHMM; BOS E; BOSMAN FT
    COLLAGEN CONTENT AND DISTRIBUTION IN THE NORMAL AND TRANSPLANTED HUMAN HEART - A POSTMORTEM QUANTITATIVE LIGHT-MICROSCOPIC ANALYSIS
    Cardiovascular pathology
    
    R.J. Vansuylen et al., "COLLAGEN CONTENT AND DISTRIBUTION IN THE NORMAL AND TRANSPLANTED HUMAN HEART - A POSTMORTEM QUANTITATIVE LIGHT-MICROSCOPIC ANALYSIS", Cardiovascular pathology, 5(2), 1996, pp. 61-68
52. BAAN CC; NIESTERS HGM; BALK AHMM; MOCHTAR B; ZONDERVAN PE; WEIMAR W
    THE INTRAGRAFT CYTOKINE MESSENGER-RNA PATTERN REFLECTS THE EFFICACY OF STEROID ANTIREJECTION THERAPY
    The Journal of heart and lung transplantation
    
    C.C. Baan et al., "THE INTRAGRAFT CYTOKINE MESSENGER-RNA PATTERN REFLECTS THE EFFICACY OF STEROID ANTIREJECTION THERAPY", The Journal of heart and lung transplantation, 15(12), 1996, pp. 1184-1193
53. DEVITOHAYNES LD; JANKOWSKAGAN E; HEISEY D; JUTTE NHPM; BALK AHMM; WEIMAR W; CLAAS FHJ; WARNER TFC; MENTZER RM; LOVE RB; BURLINGHAM WJ
    DONOR-DERIVED HUMAN-LEUKOCYTE ANTIGEN CLASS-I PROTEINS IN THE SERUM OF HEART-TRANSPLANT RECIPIENTS
    The Journal of heart and lung transplantation
    
    L.D. Devitohaynes et al., "DONOR-DERIVED HUMAN-LEUKOCYTE ANTIGEN CLASS-I PROTEINS IN THE SERUM OF HEART-TRANSPLANT RECIPIENTS", The Journal of heart and lung transplantation, 15(10), 1996, pp. 1012-1026
54. VANTOORENENBERGEN AW; BALK AHMM; VERMEULEN AM
    SUSTAINED DECREASE OF SERUM TOTAL IGE IN CARDIAC TRANSPLANT RECIPIENTS
    International archives of allergy and immunology
    
    A.W. Vantoorenenbergen et al., "SUSTAINED DECREASE OF SERUM TOTAL IGE IN CARDIAC TRANSPLANT RECIPIENTS", International archives of allergy and immunology, 110(2), 1996, pp. 163-165
55. VANBESOUW NM; VAESSEN LMB; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    CSA THERAPY AFFECTS THE DIRECT AND INDIRECT ANTIGEN-PRESENTATION PATHWAY IN CARDIAC ALLOGRAFT RECIPIENTS
    Transplantation proceedings
    
    N.M. Vanbesouw et al., "CSA THERAPY AFFECTS THE DIRECT AND INDIRECT ANTIGEN-PRESENTATION PATHWAY IN CARDIAC ALLOGRAFT RECIPIENTS", Transplantation proceedings, 28(6), 1996, pp. 3135-3136
56. BAAN CC; NIESTERS HGM; BALK AHMM; MOCHTAR B; ZONDERVAN PE; VANGELDER T; WEIMAR W
    STEROID RESISTANCE IN CLINICAL HEART-TRANSPLANTATION - THE ROLE OF SIMULTANEOUS IL-2 AND IL-4 MESSENGER-RNA EXPRESSION
    Transplantation proceedings
    
    C.C. Baan et al., "STEROID RESISTANCE IN CLINICAL HEART-TRANSPLANTATION - THE ROLE OF SIMULTANEOUS IL-2 AND IL-4 MESSENGER-RNA EXPRESSION", Transplantation proceedings, 28(6), 1996, pp. 3239-3240
57. VANEMMERIK NEM; VAESSEN LMB; BALK AHMM; BOS E; CLAAS FHJ; WEIMAR W
    PROGRESSIVE ACCUMULATION OF CTL WITH HIGH AVIDITY FOR DONOR ANTIGENS DURING THE DEVELOPMENT OF ACUTE CARDIAC REJECTION
    Transplantation
    
    N.E.M. Vanemmerik et al., "PROGRESSIVE ACCUMULATION OF CTL WITH HIGH AVIDITY FOR DONOR ANTIGENS DURING THE DEVELOPMENT OF ACUTE CARDIAC REJECTION", Transplantation, 62(4), 1996, pp. 529-536
58. JUTTE NHPM; KNOPP CJ; HEIJSE P; BALK AHMM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    HUMAN HEART ENDOTHELIAL-CELL-RESTRICTED ALLORECOGNITION
    Transplantation
    
    N.H.P.M. Jutte et al., "HUMAN HEART ENDOTHELIAL-CELL-RESTRICTED ALLORECOGNITION", Transplantation, 62(3), 1996, pp. 403-406
59. VANGELDER T; BALK AHMM; JONKMAN FAM; ZIETSE R; ZONDERVAN P; HESSE CJ; VAESSEN LMB; MOCHTAR B; WEIMAR W
    A RANDOMIZED TRIAL COMPARING SAFETY AND EFFICACY OF OKT3 AND A MONOCLONAL ANTI-INTERLEUKIN-8 RECEPTOR ANTIBODY (BT563) IN THE PREVENTION OFACUTE REJECTION AFTER HEART-TRANSPLANTATION
    Transplantation
    
    T. Vangelder et al., "A RANDOMIZED TRIAL COMPARING SAFETY AND EFFICACY OF OKT3 AND A MONOCLONAL ANTI-INTERLEUKIN-8 RECEPTOR ANTIBODY (BT563) IN THE PREVENTION OFACUTE REJECTION AFTER HEART-TRANSPLANTATION", Transplantation, 62(1), 1996, pp. 51-55
60. VANBESOUW NM; VAESSEN LMB; DAANE CR; JUTTE NHPM; BALK AHMM; CLASS FHJ; WEIMAR W
    PERIPHERAL MONITORING OF DIRECT AND INDIRECT ALLOANTIGEN PRESENTATIONPATHWAYS IN CLINICAL HEART-TRANSPLANT RECIPIENTS
    Transplantation
    
    N.M. Vanbesouw et al., "PERIPHERAL MONITORING OF DIRECT AND INDIRECT ALLOANTIGEN PRESENTATIONPATHWAYS IN CLINICAL HEART-TRANSPLANT RECIPIENTS", Transplantation, 61(1), 1996, pp. 165-167
61. VANBESOUW NM; DAANE CR; VAESSEN LMB; BALK AHMM; CLAAS FHJ; ZONDERVAN PE; JUTTE NHPM; WEIMAR W
    DIFFERENT PATTERNS IN DONOR-SPECIFIC PRODUCTION OF T-HELPER-1 AND T-HELPER-2 CYTOKINES BY CELLS INFILTRATING THE REJECTING CARDIAC ALLOGRAFT
    The Journal of heart and lung transplantation
    
    N.M. Vanbesouw et al., "DIFFERENT PATTERNS IN DONOR-SPECIFIC PRODUCTION OF T-HELPER-1 AND T-HELPER-2 CYTOKINES BY CELLS INFILTRATING THE REJECTING CARDIAC ALLOGRAFT", The Journal of heart and lung transplantation, 14(5), 1995, pp. 816-823
62. VANGELDER T; MULDER AH; BALK AHMM; MOCHTAR B; HESSE CJ; BAAN CC; VAESSEN LMB; WEIMAR W
    INTEGRAFT MONITORING OF REJECTION AFTER PROPHYLACTIC TREATMENT WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN HEART-TRANSPLANT RECIPIENTS
    The Journal of heart and lung transplantation
    
    T. Vangelder et al., "INTEGRAFT MONITORING OF REJECTION AFTER PROPHYLACTIC TREATMENT WITH MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN HEART-TRANSPLANT RECIPIENTS", The Journal of heart and lung transplantation, 14(2), 1995, pp. 346-350
63. ZIETSE R; BLANKESTIJN PJ; POS B; BALK AHMM; DERKX FHM; WEIMAR W; SCHALEKAMP MADH
    OPTIMIZING GLOMERULAR-FILTRATION RATE AND EFFECTIVE RENAL PLASMA-FLOWMEASUREMENTS USING A SIMPLE PHARMACOKINETIC MODEL
    Clinical nephrology
    
    R. Zietse et al., "OPTIMIZING GLOMERULAR-FILTRATION RATE AND EFFECTIVE RENAL PLASMA-FLOWMEASUREMENTS USING A SIMPLE PHARMACOKINETIC MODEL", Clinical nephrology, 43(1), 1995, pp. 29-34
64. HESSE CJ; VANGELDER T; VAESSEN LMB; KNOOP CJ; BALK AHMM; YZERMANS JNM; JUTTE NHPM; WEIMAR W
    PHARMACODYNAMICS OF PROPHYLACTIC ANTIREJECTION THERAPY WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (BT563) AFTER HEART AND KIDNEY-TRANSPLANTATION
    Immunopharmacology
    
    C.J. Hesse et al., "PHARMACODYNAMICS OF PROPHYLACTIC ANTIREJECTION THERAPY WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (BT563) AFTER HEART AND KIDNEY-TRANSPLANTATION", Immunopharmacology, 30(3), 1995, pp. 237-246
65. BAAN CC; VAESSEN LMB; LOONEN EHM; BALK AHMM; JUTTE NHPM; CLAAS FHJ; WEIMAR W
    THE EFFECT OF ANTITHYMOCYTE GLOBULIN THERAPY ON FREQUENCY AND AVIDITYOF ALLOSPECIFIC COMMITTED CTL IN CLINICAL HEART-TRANSPLANTS
    Transplantation proceedings
    
    C.C. Baan et al., "THE EFFECT OF ANTITHYMOCYTE GLOBULIN THERAPY ON FREQUENCY AND AVIDITYOF ALLOSPECIFIC COMMITTED CTL IN CLINICAL HEART-TRANSPLANTS", Transplantation proceedings, 27(1), 1995, pp. 482-484
66. VAESSEN LMB; BAAN CC; DAANE CR; LOONEN EHM; BALK AHMM; JUTTE NHPM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    IMMUNOLOGICAL MONITORING IN PERIPHERAL-BLOOD AFTER HEART-TRANSPLANTATION - FREQUENCIES OF T-HELPER CELLS AND PRECURSORS OF CYTOTOXIC T-CELLS WITH HIGH AVIDITY FOR DONOR ANTIGENS CORRELATE WITH REJECTION
    Transplantation proceedings
    
    L.M.B. Vaessen et al., "IMMUNOLOGICAL MONITORING IN PERIPHERAL-BLOOD AFTER HEART-TRANSPLANTATION - FREQUENCIES OF T-HELPER CELLS AND PRECURSORS OF CYTOTOXIC T-CELLS WITH HIGH AVIDITY FOR DONOR ANTIGENS CORRELATE WITH REJECTION", Transplantation proceedings, 27(1), 1995, pp. 485-487
67. VANGELDER T; KNOOP CJ; HESSE CJ; VAESSEN LMB; BALK AHMM; YZERMANS JNM; WEIMAR W
    PERIPHERAL-BLOOD MONITORING DURING AND AFTER REJECTION-PROPHYLAXIS WITH A MONOCLONAL ANTI-INTERLEUKIN-2-RECEPTOR ANTIBODY IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS
    Transplantation proceedings
    
    T. Vangelder et al., "PERIPHERAL-BLOOD MONITORING DURING AND AFTER REJECTION-PROPHYLAXIS WITH A MONOCLONAL ANTI-INTERLEUKIN-2-RECEPTOR ANTIBODY IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS", Transplantation proceedings, 27(1), 1995, pp. 856-858
68. ARNESE M; CORNEL JH; SALUSTRI A; MAAT APWM; ELHENDY A; REIJS AEM; TENCATE FJ; KEANE D; BALK AHMM; ROELANDT JRTC; FIORETTI PM
    PREDICTION OF IMPROVEMENT OF REGIONAL LEFT-VENTRICULAR FUNCTION AFTERSURGICAL REVASCULARIZATION - A COMPARISON OF LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY WITH TL-201 SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY
    Circulation
    
    M. Arnese et al., "PREDICTION OF IMPROVEMENT OF REGIONAL LEFT-VENTRICULAR FUNCTION AFTERSURGICAL REVASCULARIZATION - A COMPARISON OF LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY WITH TL-201 SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY", Circulation, 91(11), 1995, pp. 2748-2752
69. OUWEHAND AJ; BAAN CC; VAESSEN LMB; JUTTE NHPM; BALK AHMM; BOS E; CLAAS FHJ; WEIMAR W
    CHARACTERISTICS OF GRAFT-INFILTRATING LYMPHOCYTES AFTER HUMAN HEART-TRANSPLANTATION - HLA MISMATCHES AND THE CELLULAR IMMUNE-RESPONSE WITHIN THE TRANSPLANTED HEART
    Human immunology
    
    A.J. Ouwehand et al., "CHARACTERISTICS OF GRAFT-INFILTRATING LYMPHOCYTES AFTER HUMAN HEART-TRANSPLANTATION - HLA MISMATCHES AND THE CELLULAR IMMUNE-RESPONSE WITHIN THE TRANSPLANTED HEART", Human immunology, 39(4), 1994, pp. 233-242
70. KROES ACM; DEMAN RA; NIESTERS HGM; SCHALM SW; WEIMAR W; BALK AHMM
    FATAL HEPATITIS-C VIRUS-INFECTION IN A HEART-TRANSPLANT RECIPIENT DETECTABLE BY POLYMERASE CHAIN-REACTION ONLY
    Journal of hepatology
    
    A.C.M. Kroes et al., "FATAL HEPATITIS-C VIRUS-INFECTION IN A HEART-TRANSPLANT RECIPIENT DETECTABLE BY POLYMERASE CHAIN-REACTION ONLY", Journal of hepatology, 21(6), 1994, pp. 1113-1115
71. OUWEHAND AJ; BALK AHMM; BAAN CC; VAESSEN LMB; JUTTE NHPM; BOS E; CLAAS FHJ; WEIMAR W
    CYTOMEGALOVIRUS-INFECTION AND ALLOSPECIFIC CYTOTOXIC ACTIVITY OF GRAFT-INFILTRATING CELLS AFTER HEART-TRANSPLANTATION
    Journal of medical virology
    
    A.J. Ouwehand et al., "CYTOMEGALOVIRUS-INFECTION AND ALLOSPECIFIC CYTOTOXIC ACTIVITY OF GRAFT-INFILTRATING CELLS AFTER HEART-TRANSPLANTATION", Journal of medical virology, 42(2), 1994, pp. 175-181
72. BAAN CC; VAESSEN LMB; BALK AHMM; MOCHTAR B; JUTTE NHPM; CLAAS FHJ; WEIMAR W
    CYCLOSPORINE-A SENSITIVITY OF ALLO-SPECIFIC PRECURSOR AND COMMITTED CYTOTOXIC T-LYMPHOCYTES AFTER CLINICAL HEART-TRANSPLANTATION
    Transplantation proceedings
    
    C.C. Baan et al., "CYCLOSPORINE-A SENSITIVITY OF ALLO-SPECIFIC PRECURSOR AND COMMITTED CYTOTOXIC T-LYMPHOCYTES AFTER CLINICAL HEART-TRANSPLANTATION", Transplantation proceedings, 26(5), 1994, pp. 2849-2851
73. VAESSEN LMB; BAAN CC; OUWEHAND AJ; BALK AHMM; JUTTE NHPM; MOCHTAR B; CLAAS FHJ; WEIMAR W
    DIFFERENTIAL AVIDITY AND CYCLOSPORINE SENSITIVITY OF COMMITTED DONOR-SPECIFIC GRAFT-INFILTRATING CYTOTOXIC T-CELLS AND THEIR PRECURSORS - RELEVANCE FOR CLINICAL CARDIAC GRAFT-REJECTION
    Transplantation
    
    L.M.B. Vaessen et al., "DIFFERENTIAL AVIDITY AND CYCLOSPORINE SENSITIVITY OF COMMITTED DONOR-SPECIFIC GRAFT-INFILTRATING CYTOTOXIC T-CELLS AND THEIR PRECURSORS - RELEVANCE FOR CLINICAL CARDIAC GRAFT-REJECTION", Transplantation, 57(7), 1994, pp. 1051-1059
74. JUTTE NHPM; GROENEVELD K; BALK AHMM; OUWEHAND AJ; LOONEN EHM; VANDERLINDEN M; STRIKWERDA S; MOCHTAR B; CLAAS FHJ; WEIMAR W
    THE DEVELOPMENT OF TRANSPLANT CORONARY-ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION IS CORRELATED WITH A PREDOMINANCE OF CD8(-LYMPHOCYTES IN ENDOMYOCARDIAL BIOPSY DERIVED T-CELL CULTURES() T)
    Clinical and experimental immunology
    
    N.H.P.M. Jutte et al., "THE DEVELOPMENT OF TRANSPLANT CORONARY-ARTERY DISEASE AFTER CARDIAC TRANSPLANTATION IS CORRELATED WITH A PREDOMINANCE OF CD8(-LYMPHOCYTES IN ENDOMYOCARDIAL BIOPSY DERIVED T-CELL CULTURES() T)", Clinical and experimental immunology, 98(1), 1994, pp. 158-162
75. BAAN CC; VANEMMERIK NEM; BALK AHMM; QUINT WGV; MOCHTAR B; JUTTE NHPM; NIESTERS HGM; WEIMAR W
    CYTOKINE MESSENGER-RNA EXPRESSION IN ENDOMYOCARDIAL BIOPSIES DURING ACUTE REJECTION FROM HUMAN HEART-TRANSPLANTS
    Clinical and experimental immunology
    
    C.C. Baan et al., "CYTOKINE MESSENGER-RNA EXPRESSION IN ENDOMYOCARDIAL BIOPSIES DURING ACUTE REJECTION FROM HUMAN HEART-TRANSPLANTS", Clinical and experimental immunology, 97(2), 1994, pp. 293-298
76. IDEMA RN; VANDENMEIRACKER AH; BALK AHMM; BOS E; SCHALEKAMP MADH; TVELD AJMI
    ABNORMAL DIURNAL-VARIATION OF BLOOD-PRESSURE, CARDIAC-OUTPUT, AND VASCULAR-RESISTANCE IN CARDIAC TRANSPLANT RECIPIENTS
    Circulation
    
    R.N. Idema et al., "ABNORMAL DIURNAL-VARIATION OF BLOOD-PRESSURE, CARDIAC-OUTPUT, AND VASCULAR-RESISTANCE IN CARDIAC TRANSPLANT RECIPIENTS", Circulation, 90(6), 1994, pp. 2797-2803
77. IDEMA RN; VANDENMEIRACKER AH; BALK AHMM; BOS E; SCHALEKAMP MADH; MANINTVELD AJ
    DECREASED CIRCADIAN BLOOD-PRESSURE VARIATION UP TO 3 YEARS AFTER HEART-TRANSPLANTATION
    The American journal of cardiology
    
    R.N. Idema et al., "DECREASED CIRCADIAN BLOOD-PRESSURE VARIATION UP TO 3 YEARS AFTER HEART-TRANSPLANTATION", The American journal of cardiology, 73(13), 1994, pp. 1006-1009
78. BALK AHMM; WEIMAR W; ROTHBARTH PH; MEETER K; METSELAAR HJ; MOCHTAR B; SIMOONS ML
    PASSIVE-IMMUNIZATION AGAINST CYTOMEGALOVIRUS IN ALLOGRAFT RECIPIENTS - THE ROTTERDAM HEART-TRANSPLANT PROGRAM EXPERIENCE
    Infection
    
    A.H.M.M. Balk et al., "PASSIVE-IMMUNIZATION AGAINST CYTOMEGALOVIRUS IN ALLOGRAFT RECIPIENTS - THE ROTTERDAM HEART-TRANSPLANT PROGRAM EXPERIENCE", Infection, 21(4), 1993, pp. 195-200
79. IDEMA RN; VANDENMEIRACKER AH; MANINTVELD AJ; BALK AHMM; BOS E; SCHALEKAMP MADH
    CIRCADIAN HEMODYNAMICS IN HEART-TRANSPLANT RECIPIENTS
    Journal of hypertension
    
    R.N. Idema et al., "CIRCADIAN HEMODYNAMICS IN HEART-TRANSPLANT RECIPIENTS", Journal of hypertension, 11, 1993, pp. 190000090-190000091
80. VANDENMEIRACKER AH; TULEN JHM; MANINTVELD AJ; BALK AHMM; VANSTEENIS HG; SCHALEKAMP MADH
    BLOOD-PRESSURE AND HEART-RATE-VARIABILITY IN CLINICAL-MODELS OF CARDIAC DENERVATION, SYMPATHICOLYSIS AND SYMPATHICO- AND PARASYMPATHICOLYSIS
    Journal of hypertension
    
    A.H. Vandenmeiracker et al., "BLOOD-PRESSURE AND HEART-RATE-VARIABILITY IN CLINICAL-MODELS OF CARDIAC DENERVATION, SYMPATHICOLYSIS AND SYMPATHICO- AND PARASYMPATHICOLYSIS", Journal of hypertension, 11, 1993, pp. 190000152-190000153
81. OUWEHAND AJ; BAAN CC; ROELEN DL; VAESSEN LMB; BALK AHMM; JUTTE NHPM; BOS E; CLAAS FHJ; WEIMAR W
    THE DETECTION OF CYTOTOXIC T-CELLS WITH HIGH-AFFINITY RECEPTORS FOR DONOR ANTIGENS IN THE TRANSPLANTED HEART AS A PROGNOSTIC FACTOR FOR GRAFT-REJECTION
    Transplantation
    
    A.J. Ouwehand et al., "THE DETECTION OF CYTOTOXIC T-CELLS WITH HIGH-AFFINITY RECEPTORS FOR DONOR ANTIGENS IN THE TRANSPLANTED HEART AS A PROGNOSTIC FACTOR FOR GRAFT-REJECTION", Transplantation, 56(5), 1993, pp. 1223-1229
82. GROEN HJM; BOGAARD JM; BALK AHMM; KHO SG; HOP WCJ; HILVERING C
    DIFFUSION CAPACITY IN HEART-TRANSPLANT RECIPIENTS
    Chest
    
    H.J.M. Groen et al., "DIFFUSION CAPACITY IN HEART-TRANSPLANT RECIPIENTS", Chest, 104(6), 1993, pp. 1938-1939
83. DIMARIO C; KRAMS R; BALK AHMM; VERDOUW PD; ROELANDT JRTC
    CAN THE ZERO-FLOW PRESSURE BE EXTRAPOLATED FROM THE FLOW VELOCITY-PRESSURE RELATION DURING LONG DIASTOLIC PAUSES IN HUMANS
    Circulation
    
    C. Dimario et al., "CAN THE ZERO-FLOW PRESSURE BE EXTRAPOLATED FROM THE FLOW VELOCITY-PRESSURE RELATION DURING LONG DIASTOLIC PAUSES IN HUMANS", Circulation, 88(4), 1993, pp. 204-204